Predictions of Systemic, Intracellular, and Lung Concentrations of Azithromycin With Different Dosing Regimens Used in COVID‐19 Clinical Trials-Reference-Cited by-同舟云学术

Predictions of Systemic, Intracellular, and Lung Concentrations of Azithromycin With Different Dosing Regimens Used in COVID‐19 Clinical Trials

Published:2020-07-15 Issue:8 Volume:9 Page:435-443
ISSN:2163-8306
Container-title:CPT: Pharmacometrics & Systems Pharmacology
language:en
Short-container-title:CPT Pharmacometrics Syst. Pharmacol.

Author:

Hughes Jim H.¹,Sweeney Kevin¹,Ahadieh Sima¹,Ouellet Daniele¹²

Affiliation:

1. Pfizer Global Research and Development Groton Connecticut USA

2. Pfizer Global Research and Development Collegeville Pennsylvania USA

Funder

Pfizer

Publisher

Wiley

Subject

Pharmacology (medical),Modeling and Simulation

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/psp4.12537

Reference25 articles.

1. Hydroxychloroquine and azithromycin as a treatment of COVID‐19: results of an open‐label non‐randomized clinical trial;Gautret P.;Int. J. Antimibrob. Agents

2. Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID‐19 patients with at least a six‐day follow up: an observation study;Gautret P.;Travel Med. Infect. Dis.

3. Clinical pharmacology perspectives on the antiviral activity of azithromycin and use in COVID‐19;Damle B.;Clin. Pharmacol. Therapeut

4. Touret F.et al.In vitro screening of a FDA approved chemical library reveals potential inhibitors of SARS‐CoV‐2 replication. bioRxiv. 10.1101/2020.04.03.023846. [epub ahead of print].

5. Development of a Population Pharmacokinetic Model Characterizing the Tissue Distribution of Azithromycin in Healthy Subjects

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhaled dry powder liposomal azithromycin for treatment of chronic lower respiratory tract infection;International Journal of Pharmaceutics;2024-03

2. Local Delivery of Azithromycin Nanoformulation Attenuated Acute Lung Injury in Mice;Molecules;2022-11-28

3. A comprehensive design for prevention and management of COVID-19 in a tertiary medical institution in Bangladesh;The Journal of Infection in Developing Countries;2022-08-30

4. Macrolide Treatment Failure due to Drug–Drug Interactions: Real-World Evidence to Evaluate a Pharmacological Hypothesis;Pharmaceutics;2022-03-25

5. Lung Delivery Systems to Optimize Pharmacotherapy of COVID-19: A Concise Review;Journal of Pharmaceutical Research International;2021-09-11